{"id":"https://openalex.org/W7220697250","doi":"https://doi.org/10.5281/zenodo.23183210","title":"Assessment of Central Macular Thickness in Diabetic Macular Edema Patients Before and After Anti-VEGF (Ranibizumab) Injection","display_name":"Assessment of Central Macular Thickness in Diabetic Macular Edema Patients Before and After Anti-VEGF (Ranibizumab) Injection","publication_year":2026,"publication_date":"2026-10-06","ids":{"openalex":"https://openalex.org/W7220697250","doi":"https://doi.org/10.5281/zenodo.23183210"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23183210","doi":"https://doi.org/10.5281/zenodo.23183210","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23183210","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23183210","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157746330","display_name":"Iamonlang Kharbangar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iamonlang Kharbangar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115579434","display_name":"Haziel Rynjah","orcid":"https://orcid.org/0009-0004-8249-7010","observed_orcids":["https://orcid.org/0009-0004-8249-7010"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haziel Rynjah","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106385334","display_name":"Lipika Kalita","orcid":"https://orcid.org/0009-0000-5151-0594","observed_orcids":["https://orcid.org/0009-0000-5151-0594"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lipika Kalita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157749282","display_name":"Joyshree Das","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joyshree Das","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060008872","display_name":"Yukti Singh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yukti Singh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100570662","display_name":"Ayush Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ayush Wilson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":1.0},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/central-macular-thickness","display_name":"central macular thickness","score":0.9959999918937683},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.9279999732971191},{"id":"https://openalex.org/keywords/optical-coherence-tomography","display_name":"optical coherence tomography","score":0.8109999895095825},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9229000210762024},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7754999995231628},{"id":"https://openalex.org/C2985127711","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic macular edema","level":4,"score":0.7735999822616577},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.7681000232696533},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.7473000288009644},{"id":"https://openalex.org/C2778818243","wikidata":"https://www.wikidata.org/wiki/Q899552","display_name":"Optical coherence tomography","level":2,"score":0.6776000261306763},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.4722999930381775},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3450999855995178},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.3384000062942505},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.3156000077724457},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.296099990606308},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.27950000762939453},{"id":"https://openalex.org/C2776148792","wikidata":"https://www.wikidata.org/wiki/Q3041498","display_name":"Eye disease","level":2,"score":0.27570000290870667}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23183210","doi":"https://doi.org/10.5281/zenodo.23183210","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23183210","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23183211","doi":"https://doi.org/10.5281/zenodo.23183211","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23183211","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23183210","doi":"https://doi.org/10.5281/zenodo.23183210","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23183210","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7161638580","https://openalex.org/W2734477430","https://openalex.org/W4362511091","https://openalex.org/W2998493792","https://openalex.org/W7082367513","https://openalex.org/W8098734","https://openalex.org/W2989751165","https://openalex.org/W4221084379","https://openalex.org/W4309376802","https://openalex.org/W2982026403"],"abstract_inverted_index":{"Objective:To":[0],"assess":[1,184],"the":[2,42,87,185],"central":[3,60,137],"macular":[4,11,61,138,162],"thickness":[5,62,139],"and":[6,16,50,59,78,178,191],"visual":[7,56,148,171,192],"acuity":[8,57,149],"in":[9,82,108,133,136,140,147],"diabetic":[10],"edema":[12],"(DME)":[13],"patients":[14,37],"pre-":[15],"post-anti-vascular":[17],"endothelial":[18],"growth":[19],"factor":[20],"(VEGF)":[21],"ranibizumab":[22,47],"injection.Methods:A":[23],"prospective,":[24],"hospital-based":[25],"study":[26],"was":[27,110,150],"conducted":[28],"at":[29,70],"Bansara":[30],"Eye":[31],"Care":[32],"Centre,":[33],"Shillong,":[34],"on":[35,188],"33":[36],"(41":[38],"eyes)":[39],"treated":[40],"with":[41,92,113,175],"first":[43,88],"dose":[44,89],"of":[45,90],"anti-VEGF":[46,157],"injection.":[48],"Pre-":[49],"post-treatment":[51],"assessments":[52],"included":[53],"best":[54],"corrected":[55],"(BCVA)":[58],"(CMT)":[63],"measured":[64],"using":[65],"optical":[66],"coherence":[67],"tomography":[68],"(OCT)":[69],"baseline,":[71],"1":[72,74],"week,":[73],"month,":[75],"3":[76],"months,":[77],"6":[79],"months.Results:Significant":[80],"reductions":[81],"CMT":[83,190],"were":[84],"observed":[85],"after":[86],"ranibizumab,":[91],"values":[93,115],"decreasing":[94],"from":[95,119],"342.15":[96],"\u00b1":[97,101,122,128],"103.93\u00b5m":[98],"to":[99,124,169,183],"293.7":[100],"81.95\u00b5m":[102],"(p=0.000).":[103],"However,":[104],"no":[105,144],"significant":[106,134,145,170],"improvement":[107,146],"BCVA":[109,114],"noted":[111],"post-treatment,":[112],"remaining":[116],"relatively":[117],"unchanged":[118],"baseline":[120],"(0.60":[121],"0.40)":[123],"6-month":[125],"follow-up":[126,177],"(0.64":[127],"0.57)":[129],"(p=0.714).Conclusion:Ranibizumab":[130],"injections":[131,180],"resulted":[132],"reduction":[135],"DME":[141],"patients,":[142],"but":[143],"observed.":[151],"These":[152],"findings":[153],"suggest":[154],"that":[155],"while":[156],"treatment":[158],"may":[159,165],"help":[160],"reduce":[161],"edema,":[163],"it":[164],"not":[166],"always":[167],"lead":[168],"improvement.":[172],"Further":[173],"studies":[174],"extended":[176],"multiple":[179],"are":[181],"needed":[182],"long-term":[186],"effects":[187],"both":[189],"acuity.":[193]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-10-07T00:00:00"}